# Studying Complement Inhibition in Complex Cardiac Surgery

> **NCT02866825** · PHASE2 · COMPLETED · sponsor: **InflaRx GmbH** · enrollment: 116 (actual)

## Conditions studied

- Systemic Inflammatory Response Syndrome
- C.Surgical Procedure; Cardiac

## Interventions

- **BIOLOGICAL:** IFX-1
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02866825
- **Lead sponsor:** InflaRx GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02866825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02866825, "Studying Complement Inhibition in Complex Cardiac Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02866825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*